Mepolizumab: Therapeutic strategy for a pediatric patient with eosinophilic granulomatosis with polyangiitis

被引：3

作者：

Ozola, Lota ^{[1
,2
]}

Aleksejeva, Elina ^{[1
,2
]}

Stoldere, Diana ^{[1
,2
,5
]}

Davidsone, Zane ^{[1
,2
]}

Santere, Ruta ^{[2
]}

Grantina, Ineta ^{[1
,2
]}

Cirule, Ieva ^{[1
,2
]}

Krams, Alvils ^{[3
,4
]}

机构：

[1] Riga Stradins Univ, Dept Paediat, Riga, Latvia

[2] Childrens Clin Univ Hosp, Clin Pediat Dis, Riga, Latvia

[3] Riga East Clin Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia

[4] Univ Latvia, Dept Internal Med, Riga, Latvia

[5] Childrens Clin Univ Hosp, Vienibas gatve 45, LV-1004 Riga, Latvia

来源：

PEDIATRIC PULMONOLOGY | 2023年 / 58卷 / 03期

关键词：

mepolizumab in pediatrics; pediatric EGPA; small vessel vasculitis; CHURG-STRAUSS-SYNDROME; AMERICAN-COLLEGE; ALLERGIC GRANULOMATOSIS; CHILDHOOD; CLASSIFICATION; CRITERIA;

D O I：

10.1002/ppul.26249

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome) is classified as an antineutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis. It is a multisystem disorder and can affect every organ system. EGPA is a rare disease, with an estimated prevalence of 1/70,000-100,000 in Europe. As its onset usually occurs in adulthood, data from pediatric patients are limited. We present here a very rare practical EGPA clinical case involving a pediatric patient. Presently, data on mepolizumab usage in pediatric patients are limited, with only a few case reports published.

引用

页码：973 / 979

页数：7

共 50 条

[21] Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Sun, Ryan
Wei, Lee-Jen
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (20):
[22] SEQUENTIAL RITUXIMAB AND MEPOLIZUMAB IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Bettiol, A.
Urban, M. L.
Bello, F.
Fiori, D.
Mattioli, I.
Lopalco, G.
Iannone, F.
Egan, A.
Moroni, L.
Dagna, L.
Caminati, M.
Negrini, S.
Cameli, P.
Folci, M.
Toniati, P.
Padoan, R.
Flossmann, O.
Solans-Laque, R.
Losappio, L.
Schroeder, J.
Andre, M.
Moi, L.
Parronchi, P.
Conti, F.
Sciascia, S.
Jayne, D.
Vaglio, A.
Emmi, G.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 362 - 363
[23] Eosinophilic Granulomatosis with Polyangiitis Patient Characteristics and Clinical Response to Mepolizumab Compared to Placebo
Steinfeld, J.
Mallett, S.
Brown, J.
Bradford, E. S.
Yancey, S.
Wechsler, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[24] Efficacy of Increasing the Dose of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
Pallotti, Federica
Bonniaud, Philippe
Smets, Perrine
Habib, Stephanie
Perier, Amandine
Deroux, Alban
Mankikian, Julie
Neel, Antoine
Rousselin, Clementine
Seror, Raphaele
Taille, Camille
Crickx, Etienne
La Croix, Candice
Blanche, Philippe
Guillevin, Loic
Puechal, Xavier
Terrier, Benjamin
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3259 - 3261
[25] Low Dose of Mepolizumab in Treatment of Eosinophilic Granulomatosis with Polyangiitis
Maia, A. P.
San Martin, S. R.
Erazo, A. C. E.
Toledo, A. P.
Oliveira, E. P.
Assuncao, G. L.
Barbas, C. S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[26] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
Diaz-Campos, R. M.
Prudencio-Ribera, V. C.
Garcia-Moguel, I
Fernandez-Rodriguez, C.
Corral-Blanco, M.
Jarrin-Estupinan, M. E.
Melero-Moreno, C.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
[27] Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
Pradhan, Ravi Ranjan
Nepal, Gaurav
Mandal, Shobha
PULMONARY MEDICINE, 2019, 2019
[28] MEPOLIZUMAB INDUCTION THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Goldstein, M.
Vadaketh, K.
Dvorin, D.
Belecanech, G.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
[29] Eosinophilic Granulomatosis with Polyangiitis: Mepolizumab recommended in current Guideline
Fessler, Beate
ALLERGO JOURNAL, 2024, 33 (07) : 49 - 51
[30] MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN REAL WORLD DATA
Shoda, T.
Takeuchi, T.
Nagai, K.
Konma, J.
Arawaka, S.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 689 - 689

← 1 2 3 4 5 →